Ahnak and Cdc37 were significantly downregulated in JL-DCIS-3 as well as in all invasive BC stages relative to non-diseased contralateral JL-DCIS-3 and JL-BRL-6 (all p < 0.04) (Figure 3, Table 1). Here, AHNAK is linked to ductal breast carcinoma in situ.